FDC Share Price
Small Cap | Pharmaceuticals and health care | NSE: FDC | BSE: 531599
₹390.15 -7.35 (-1.85 %)
Last Updated: 13 Mar 2025 12:00 AM
Overview
Open (₹) 394.10
High (₹) 394.85
Low (₹) 388.05
Prev. Close (₹) 397.50
Volume 5,955
VWAP (₹) 378.76
ROCE (%) 18.55
Industry P/E 43.95
TTM P/E 23.15
P/B Ratio 3.03
Market Cap (₹) Cr.6,364.25
Dividend Yield (%)--
EPS (₹) 18.58
ROE14.42%
Sales Growth (%) 8.92
Profit Growth (%)57.39
Day Range
394.85394.85
52 Week Range
364.25659.00
Historical Returns
Returns (6M)
-32.66 %
Returns (1Y)
-8.74 %
Returns (3Y)
49.45 %
Returns (5Y)
86.01 %
Returns (6M)
-32.66 %
Returns (1Y)
-8.74 %
Returns (3Y)
49.45 %
Returns (5Y)
86.01 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (59.35%) TTM EPS Growth
- Company with no debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 59.35% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 12.28
MFI 18.83
ATR 18.42
Commodity Channel Index -104.80
ROC125 -27.90
ROC21 -19.90
Williams %R -89.51
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 389.50 | 397.15 | 406.55 | 380.10 | 372.45 | 363.05 | 355.40 |
Week Ago | 412.19 | 421.97 | 429.34 | 404.82 | 395.04 | 387.67 | 377.89 |
Month Ago | 471.90 | 479.90 | 485.95 | 465.85 | 457.85 | 451.80 | 443.80 |
EMA & SMA
390.15
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 397.95
9 Day 401.36
10 Day 401.67
12 Day 416.75
14 Day 419.33
20 Day 436.68
26 Day 443.55
50 Day 467.82
100 Day 492.59
200 Day 497.07
Deals & Announcements
Bulk and Block Deals
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
03 Apr, 2024 | Nomita Ramdas Chandavarkar | Acquisition | ₹ | 3,16,56,049 | BSE |
03 Apr, 2024 | Meera Ramdas Chandavarkar | Disposal | ₹ | 3,16,56,049 | BSE |
09 Jun, 2022 | Melarkode Ganesan Parmeswaran | Acquisition | ₹246.59 | 3,700 | BSE |
10 Oct, 2020 | MEERA R. CHANDAVARKAR | Disposal | ₹450.00 | 3,63,501 | BSE |
10 Oct, 2020 | ADITI C. BHANOT | Disposal | ₹450.00 | 12,755 | BSE |
10 Oct, 2020 | NOMITA R. CHANDAVARKAR | Disposal | ₹450.00 | 60,407 | BSE |
10 Oct, 2020 | NANDAN M. CHANDAVARKAR | Disposal | ₹450.00 | 57,886 | BSE |
10 Oct, 2020 | NANDAN M. CHANDAVARKAR in capacity of trustee of Sandhya Mohan Chandavarkar Trust | Disposal | ₹450.00 | 2,05,742 | BSE |
10 Oct, 2020 | AMEYA A. CHANDAVARKAR in capacity of Director of Virgo Advisors Private Limited | Disposal | ₹450.00 | 1,14,332 | BSE |
10 Oct, 2020 | ASHOK A. CHANDAVARKAR in capacity of Director of Leo Advisors Private Limited | Disposal | ₹450.00 | 1,71,497 | BSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
07 Nov, 2024 | Rs.5.0000 per share(500%)First Interim Dividend | 22 Nov, 2024 | 22 Nov, 2024 |
09 Mar, 2020 | Rs.0.8000 per share(80%)Interim Dividend | 19 Mar, 2020 | 21 Mar, 2020 |
Announcements
Date | Source | Detail |
---|---|---|
19 Feb, 2025 | NSE India | FDC Limited has informed the Exchange about order received from Commissioner of Custom |
19 Feb, 2025 | BSE India | Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 |
12 Feb, 2025 | BSE India | Integrated Filing (Financial) - Unaudited Financial results for the quarter and nine months ended December 31, 2024 |
12 Feb, 2025 | NSE India | Integrated Filing (Financial) - Unaudited Financial Results of FDC Limited for the quarter and nine months ended 31st December 2024 |
12 Feb, 2025 | BSE India | Press release in relation to unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024. |
12 Feb, 2025 | NSE India | press release dated February 12, 2025 of FDC Limited for the quarter and nine months ended December 31st 2024 |
12 Feb, 2025 | BSE India | PFA results for Quarter and Nine months ended December 31, 2024 |
12 Feb, 2025 | NSE India | FDC Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024. |
12 Feb, 2025 | NSE India | FDC Limited has informed the Exchange regarding Board meeting held on February 12, 2025. |
12 Feb, 2025 | BSE India | We hereby inform that the Board at its meeting held on February 12, 2025 has inter alia approved the unaudited (Standalone and Consolidated) Financial results for Quarter and nine months ended 31st December, 2024. |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results & Others | To consider others business matters. | 10 Feb, 2025 | 12 Feb, 2025 |
Quarterly Results & Others | To consider others business matters. | 10 Feb, 2025 | 06 Nov, 2024 |
Quarterly Results | -- | 29 Jul, 2024 | 07 Aug, 2024 |
Audited Results | -- | 21 May, 2024 | 29 May, 2024 |
Quarterly Results | -- | 30 Jan, 2024 | 07 Feb, 2024 |
Quarterly Results | -- | 02 Nov, 2023 | 08 Nov, 2023 |
Quarterly Results & Buy Back of shares | -- | 05 Aug, 2023 | 09 Aug, 2023 |
Audited Results | -- | 16 May, 2023 | 25 May, 2023 |
Quarterly Results | -- | 01 Feb, 2023 | 09 Feb, 2023 |
Quarterly Results | -- | 03 Nov, 2022 | 14 Nov, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
---|
About FDC
FDC is a Public Limited Listed company incorporated on 23/09/1940 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1940PLC003176 and registration number is 003176. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1916.19 Cr. and Equity Capital is Rs. 16.28 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1940
Managing Director
Mr. Mohan A Chandavarkar
NSE Symbol
FDC
FDC Management
Name | Designation |
---|---|
CA. Uday Kumar Gurkar | Chairman & Ind.Director |
Mr. Mohan A Chandavarkar | Managing Director |
Mr. Nandan M Chandavarkar | Joint Managing Director |
Mr. Ameya A Chandavarkar | Executive Director & CEO |
Mr. Ashok A Chandavarkar | Executive Director |
Ms. Nomita R Chandavarkar | Non Exe.Non Ind.Director |
CA. Swati S Mayekar | Independent Director |
Dr. Mahesh Bijlani | Independent Director |
Mr. Vijay Maniar | Independent Director |
Mr. Vijay Nautamlal Bhatt | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45 ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45 ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on FDC
What is the share price of FDC?
The share price of FDC on 13 Mar, 2025 is ₹ 390.15.
What is 52W high and 52W low share price of FDC?
The highest and lowest 52W share prices of FDC are ₹ 659.000 and ₹ 364.250
What is the market cap of FDC?
The market capitalization of FDC as of 13 Mar, 2025 is ₹ 6,364.25 Crores
What is the P/E ratio of FDC?
The current P/E ratio of FDC as of 13 Mar, 2025 is 43.95
What is the PB ratio of FDC?
The PB ratio of FDC as of 13 Mar, 2025 is 3.03
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)